Systematic review reveals positive outcomes of synthetic bone substitutes in horse treatments, indicating benefits for specific bone diseases.
In equine medicine, hydroxyapatite, calcium phosphate and β-tricalcium phosphate were the leading alloplastics applied. When applied alone, they demonstrated osteoconductive and osteoinductive properties, while the addition of biologically active additives-especially autologous bone marrow-enhanced these biological properties toward osteogenic and chondrogenic effects. Treatment outcomes were generally favourable, although segmental bone defect treatment requires considering the limitations associated with weight-bearing effects. These findings suggest alloplastics in horses may be particularly beneficial for treating certain bone diseases.
No takes yet. Share an insight, caveat, or question.
Skierbiszewska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: